HomeME • NASDAQ
23andMe Holding Co.
$0.39
Makalipas ang Oras ng Trabaho:
$0.41
(5.55%)+0.022
Sarado: Hun 28, 8:00:00 PM GMT-4 · USD · NASDAQ · Disclaimer
StockSegurong nakalista sa USMay headquarter sa US
Nakaraang pagsara
$0.42
Sakop ng araw
$0.39 - $0.44
Sakop ng taon
$0.35 - $2.03
Market cap
183.57M USD
Average na Volume
4.49M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
(USD)Mar 2024Y/Y na pagbabago
Kita
64.03M-30.69%
Gastos sa pagpapatakbo
53.15M-51.42%
Net na kita
-208.83M-225.80%
Net profit margin
-326.16-370.04%
Kita sa bawat share
-0.43-206.96%
EBITDA
-22.06M64.57%
Aktuwal na % ng binabayarang buwis
-0.01%
Kabuuang asset
Kabuuang sagutin
(USD)Mar 2024Y/Y na pagbabago
Cash at mga panandaliang investment
216.49M-44.04%
Kabuuang asset
395.17M-58.08%
Kabuuang sagutin
206.65M-9.63%
Kabuuang equity
188.52M
Natitirang share
490.26M
Presyo para makapag-book
1.11
Return on assets
-13.02%
Return on capital
-18.11%
Net change in cash
(USD)Mar 2024Y/Y na pagbabago
Net na kita
-208.83M-225.80%
Cash mula sa mga operasyon
-25.78M42.65%
Cash mula sa pag-invest
-2.15M34.73%
Cash mula sa financing
2.00M-23.25%
Net change in cash
-25.93M43.57%
Malayang cash flow
50.88M282.19%
Tungkol
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell. Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008. The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Itinatag
Abr 2006
Mga Empleyado
571
Tumuklas pa
Maaaring interesado ka sa
Nabuo ang listahang ito mula sa mga paghahanap kamakailan lang, mga sinubaybayang security, at iba pang aktibidad. Alamin pa

“As is” na ibinibigay ang lahat ng data para lang sa mga layunin sa personal na impormasyon, at hindi inilaan na maging payong pinansyal, ni hindi rin ito para sa mga layunin sa trading o investment, buwis, legal, accounting, o iba pang payo. Hindi tagapayo sa investment ang Google, ni hindi rin ito pinansyal na tagapayo at walang inihahayag na pananaw, rekomendasyon, o opinyon patungkol sa anumang kumpanyang kasama sa listahang ito o sa anumang seguridad na inisyu ng mga kumpanyang iyon. Konsultahin ang iyong broker o pampinansyal na kinatawan para ma-verify ang presyo bago magsagawa ng anumang trade. Matuto pa
Naghanap din ang mga tao ng
Search
I-clear ang paghahanap
Isara ang paghahanap
Mga app ng Google
Pangunahing menu